Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05889715 · ClinicalTrials.gov registry record · NA
Assessment of Plant-based Program Using Shared Medical Appointment
A NA study of Chronic Disease and Nutrition, Healthy, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT05889715: Completed NA study of Chronic Disease and Nutrition, Healthy, sponsored by The University of Texas Health Science Center at San Antonio.
NCT05889715 is a NA study of Chronic Disease and Nutrition, Healthy that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 47 participants, below the 89,942-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05889715, a NA study of Chronic Disease and Nutrition, Healthy, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of the impact of a whole food, plant-based (WFPB) program using shared medical appointments (SMAs) on reducing cardiovascular risk factors and weight loss in overweight/obese adults with at least one chronic disease
Primary Outcome
Change in Total Cholesterol from program beginning to end
Conditions Studied
Interventions
- OTHER Green Wellness Program: Plants-2-Plate
Study Locations (1)
Texas
- UT Health San Antonio, School of Nursing - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2024-02-07 |
| Phase | NA |
What the finished NCT05889715 record still lists
NCT05889715 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 89,942-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Chronic Disease appearing as the primary indexed condition, and to 1 intervention - of which Green Wellness Program: Plants-2-Plate is the first listed.
NCT05889715 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05889715 about?
NCT05889715 is a clinical study titled "Assessment of Plant-based Program Using Shared Medical Appointment". Evaluation of the impact of a whole food, plant-based (WFPB) program using shared medical appointments (SMAs) on reducing cardiovascular risk factors and weight loss in overweight/obese adults with at least one chronic disease
What is the current status of trial NCT05889715?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2023-05-10. Estimated completion is 2024-02-07.
What conditions does trial NCT05889715 study?
This clinical trial studies the following conditions: Chronic Disease, Nutrition, Healthy.
What interventions are being tested in trial NCT05889715?
The interventions under investigation include: Green Wellness Program: Plants-2-Plate (OTHER).
Who is sponsoring clinical trial NCT05889715?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05889715 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05889715's enrollment target sits among peer trials
47 40th of 48 higher than 9 of 48 other Chronic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Click & Pick Study
RECRUITING · NA
-
Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program
RECRUITING · NA
-
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
RECRUITING · NA
-
Comparative Effectiveness of IIMR Versus CDSMP
RECRUITING · NA
-
Training Community Members to be Coaches to Deliver the HealthyLifetime Program
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI